Login / Signup

Primary progression during frontline CIT associates with decreased efficacy of subsequent CD19 CAR T-cell therapy in LBCL.

Ariel PerezGrace JohnsonKedar PatelBrian ArciolaAnthony WoodChristina A BachmeierJulio C ChavezBijal D ShahFarhad KhimaniTaiga NishihoriAleksander LazaryanMarco L DavilaRahul MhaskarFrederick L LockeSameh GaballaMichael D Jain
Published in: Blood advances (2022)
Keyphrases
  • cell therapy
  • stem cells
  • mesenchymal stem cells
  • nk cells